Wilm's Tumor (Nephroblastoma) | PPT
Rekombinanter WT1 Antikörper (ABIN6940904)
Wilms' Tumour – Histology and Differential Diagnosis - Wilms Tumor - NCBI Bookshelf
Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis | Scientific Reports
Wilms tumor
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol | Nature Reviews Urology
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 8 (2021)
Systematic review of the immunological landscape of Wilms tumors: Molecular Therapy - Oncolytics
Two Splice Variants of the Wilms' Tumor 1 Gene Have Distinct Functions during Sex Determination and Nephron Formation: Cell
Frontiers | MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers
Wilms tumour | Nature Reviews Disease Primers
Wilms' Tumour – Histology and Differential Diagnosis - Wilms Tumor - NCBI Bookshelf
Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2-Q177R mutation | bioRxiv
Frontiers | MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers
IJMS | Free Full-Text | Identification of Apolipoprotein C-I as a Potential Wilms' Tumor Marker after Excluding Inflammatory Factors
Rekombinanter WT1 Antikörper (ABIN6940904)
New approaches to risk stratification for Wilms tumor. - Abstract - Europe PMC
Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor
The tumor suppressor WT1 drives progenitor cell progression and epithelialization to prevent Wilms tumorigenesis in human kidney organoids - ScienceDirect
Is antenatal detection of Wilms tumor a bad prognostic marker – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
